Back
United Therapeutics Stock Price Chart

Built for Lazy Summer Markets
Get instant access today.
Buy
55
UTHR
United Therapeutics
Last Price:
$295.33
Seasonality Move:
8.9%
7 Day Trial
ALL ACCESS PASS
$
7

Your Summer Trading Shortcut
Try it free today.-
The current trend is relatively stagnant and UTHR is experiencing slight buying pressure.
United Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 287.46 | Buy |
20-day SMA: | 295.81 | Sell |
50-day SMA: | 300.76 | Sell |
200-day SMA: | 337.29 | Sell |
8-day EMA: | 288.27 | Buy |
20-day EMA: | 293.36 | Sell |
50-day EMA: | 300.63 | Sell |
200-day EMA: | 316.71 | Sell |
United Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.38 | Sell |
Relative Strength Index (14 RSI): | 46.07 | Sell |
Chaikin Money Flow: | 2926 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (282.62 - 318.3) | Sell |
Bollinger Bands (100): | (286.43 - 334.99) | Sell |
United Therapeutics Technical Analysis
Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 30 | Jul 1 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | 30 | 01 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for United Therapeutics Stock
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 290.91 while UTHR 8-day simple moving average is 287.46, which is a Buy signal.
-
The stock price of UTHR is 290.91 while United Therapeutics 20-day SMA is 295.81, which makes it a Sell.
-
United Therapeutics 50-day simple moving average is 300.76 while UTHR share price is 290.91, making it a Sell technically.
-
UTHR stock price is 290.91 and United Therapeutics 200-day simple moving average is 337.29, creating a Sell signal.
UTHR Technical Analysis vs Fundamental Analysis
Buy
55
United Therapeutics (UTHR)
is a Buy
Is United Therapeutics a Buy or a Sell?
-
United Therapeutics stock is rated a BuyThe current United Therapeutics [UTHR] share price is $290.91. The Score for UTHR is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
United Therapeutics Stock Info
Market Cap:
13.1B
Price in USD:
290.91
Share Volume:
377.2K
United Therapeutics 52-Week Range
52-Week High:
417.82
52-Week Low:
266.98
Buy
55
United Therapeutics (UTHR)
is a Buy
United Therapeutics Share Price Forecast
-
What is the United Therapeutics stock price today?The United Therapeutics stock price is 290.91 USD today.
-
Will UTHR stock go up or go down?United Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is United Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, United Therapeutics is not overvalued.
Is United Therapeutics Stock a Buy?
-
United Therapeutics share price is 290.91 while UTHR 8-day exponential moving average is 288.27, which is a Buy signal.
-
The stock price of UTHR is 290.91 while United Therapeutics 20-day EMA is 293.36, which makes it a Sell.
-
United Therapeutics 50-day exponential moving average is 300.63 while UTHR share price is 290.91, making it a Sell technically.
-
UTHR stock price is 290.91 and United Therapeutics 200-day simple moving average is 316.71, creating a Sell signal.
Fundamental Analysis of United Therapeutics
Is United Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $0.74 per share, an increase next quarter of $0.15 per share, an increase this year of $2.52 per share, and an increase next year of $0.95 per share.
Technical Analysis of United Therapeutics
Should I short United Therapeutics stock?
-
UTHR Moving Average Covergence Divergence (MACD) indicator is -5.38, suggesting United Therapeutics is a Sell
-
United Therapeutics Relative Strength Index (RSI) is 46.07, which suggest United Therapeutics is oversold
-
The Bollinger Bands (25) for United Therapeutics is (282.62 - 318.3), which suggest United Therapeutics is a Sell
-
The Bollinger Bands (100) for United Therapeutics is (286.43 - 334.99), which suggest United Therapeutics is a Sell
* United Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.